Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Archives of Disease in Childhood. Education and Practice Edition|August 11, 2016
What do I need to know about aminoglycoside antibiotics?Eva Germovsek, Charlotte I Barker, Mike Sharland
Mabs|September 17, 2021
Allometric scaling of therapeutic monoclonal antibodies in preclinical and clinical settingsEva Germovsek, Ming Cheng, Craig Giragossian
Archives of Disease in Childhood. Education and Practice Edition|July 15, 2016
What do I need to know about penicillin antibiotics?Charlotte I Barker, Eva Germovsek, Mike Sharland
British Journal of Clinical Pharmacology|October 22, 2016
Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?Eva Germovsek, Charlotte I S Barker, Mike Sharland, et al.
Clinical Pharmacokinetics|April 21, 2018
Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of ClearanceEva Germovsek, Charlotte I S Barker, Mike Sharland, et al.
Clinical Pharmacokinetics|December 19, 2018
Correction to: Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of ClearanceEva Germovsek, Charlotte I S Barker, Mike Sharland, et al.
The AAPS Journal|April 28, 2019
A Novel Method for Analysing Frequent Observations from Questionnaires in Order to Model Patient-Reported Outcomes: Application to EXACT® Daily Diary Data from COPD PatientsEva Germovsek, Claire Ambery, Shuying Yang, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2019
Development and external evaluation of a population pharmacokinetic model for continuous and intermittent administration of vancomycin in neonates and infants using prospectively collected dataEva Germovsek, Leanne Osborne, Flora Gunaratnam, et al.
Advanced Drug Delivery Reviews|January 21, 2014
Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunologyCharlotte I S Barker, Eva Germovsek, Rollo L Hoare, et al.
Clinical Pharmacology and Therapeutics|August 1, 2020
A Time-to-Event Model Relating Integrated Craving to Risk of Smoking Relapse Across Different Nicotine Replacement Therapy FormulationsEva Germovsek, Anna Hansson, Mats O Karlsson, et al.
Pageof 2